New features in the correction of dysbiosis in the family doctor’s practice

Abstract

Today, the problem of intestinal dysbiosis is one of the most relevant in the work of doctors of many specialties.

There are many reasons that can cause this state. The main and most common etiologic factor is the harmful effect of antibacterial drugs on the microflora. The question of the inexpedient and uncontrolled use of antibiotics is as relevant as ever. However, there are situations when chemotherapy can’t be avoided. Infectious diseases and their treatment in this list are on the first place. Meningitis, pneumonia, bronchitis, sinusitis (including their severe purulent complications), other bacterial lesions of various organs and systems require the appointment of a powerful and often prolonged antibiotic therapy. In addition, numerous intestinal infections, viral hepatitis and pancreatitis, gastritis, cholecystitis and other diseases that develop against their background, even without the use of chemotherapy, depress and suppress normal microflora.

Thus, the main task of the doctor in prescribing an antibiotic is the timely prevention and treatment of dysbiosis. This is achieved by a set of measures, including the designation of useful microorganisms and substances.

Promising in the treatment of this pathology is using of positive therapeutic effects of prebiotics, which create favorable conditions for the functioning of endogenous microflora, stimulate the growth of bifidobacteria, which are the obligate (basic) microflora of the human intestine.

Among a large number of existing prebiotics, dietary fiber is widely used, the increased content of which contributes to an increase in the population of lactic acid microorganisms and the production of carboxylic acids having a laxative effect.

The article describes the main principles of correction of dysbiosis with the use of modern domestic enterosorbent-prebiotic Bionorm. The experience of using Bionorm in patients with intestinal dysbiosis confirms the ability of the preparation to modulate the intestinal microbiota and restore its disturbed motor-evacuation function.

The use of the Bionorm for the prevention and treatment of patients with dysbiosis is pathogenetically justified in the form of monotherapy and an effective supplement to standard treatment, which contributes to the rapid positive dynamics of the clinical picture, normalization of the stool, elimination of flatulence, discomfort in the abdomen and improvement of the quality of life of patients.